B. Ufuk Baldan

Dr. B. Ufuk Baldan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BBB. Ufuk Baldan
B. Ufuk Baldan
RHRomy R. M. J. J. Hegeman
Romy R. M. J. J. Hegeman
NBNelleke Maria Johanna Petronella Bos
Nelleke Maria Johanna Petronella Bos
HSHenri Smeenk
Henri Smeenk
RKRobert J.M. Klautz
Robert J.M. Klautz
PKPatrick Klein
Patrick Klein
Background: Post-cardiotomy cardiogenic shock (PCCS), which is defined as severe low cardiac output syndrome after cardiac surgery, has a mortality rate of up to 90%. No study has yet been performed to compare patients with PCCS treated by conservative means to patients receiving additional mechanical circulatory support with veno-arterial extracorporeal membrane oxygenation (ECMO). Methods: A single-center retrospective analysis from January 2018 to June 2022 was performed. Results: Out of 7028 patients who underwent cardiac surgery during this time period, 220 patients (3%) developed PCCS. The patients were stratified according to their severity of shock based on the Stage Classification Expert Consensus (SCAI) group. Known risk factors for shock-related mortality, including the vasoactive–inotropic score (VIS) and plasma lactate levels, were assessed at structured intervals. In patients treated additionally with ECMO (n = 73), the in-hospital mortality rate was 60%, compared to an in-hospital mortality rate of 85% in patients treated by conservative means (non-ECMO; n = 52). In 18/73 (25%) ECMO patients, the plasma lactate level normalized within 48 h, compared to 2/52 (4%) in non-ECMO patients. The morbidity of non-ECMO patients compared to ECMO patients included a need for dialysis (42% vs. 60%), myocardial infarction (19% vs. 27%), and cerebrovascular accident (17% vs. 12%). Conclusions: In conclusion, the additional use of ECMO in PCCS holds promise for enhancing outcomes in these critically ill patients, more rapid improvement of end-organ perfusion, and the normalization of plasma lactate levels.

7 January 2026 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
BBB. Ufuk Baldan
B. Ufuk Baldan
MVMariëlle C. Van de Veerdonk
Mariëlle C. Van de Veerdonk
PTPieter R. Tuinman
Pieter R. Tuinman
AEA.E. Engström
A.E. Engström
SESusanne Eberl
Susanne Eberl
PKPatrick Klein
Patrick Klein
Post-cardiotomy shock (PCS) is a severe complication after cardiac surgery, associated with high in-hospital mortality. The Society for Cardiovascular Angiography and Interventions (SCAI) SHOCK classification offers a valid approach for initial shock staging post-surgery. However, the prognostic value and accuracy of serial staging remain unclear. The aim of this study is to externally validate the prognostic value and accuracy of serial SCAI SHOCK reclassification for all-cause in-hospital mortality in PCS patients during postoperative days 1-7. Retrospective, observational, multicenter study of 9,258 adult post-cardiotomy patients from 2 Dutch tertiary centers (2015-2024). SCAI SHOCK stage was determined daily during postoperative days 1-7. Endpoint was all-cause in-hospital mortality. Discrimination was performed with area under the curve determination, calibration, and survival analyses. On postoperative day 1, 38% of all post-cardiotomy patients were classified as in shock (stage C-E), and by postoperative day 3 91% of all patients were reclassified as not in shock anymore (stage A-B). In-hospital mortality increased progressively with both higher shock stages and prolonged shock duration. SCAI SHOCK classification showed a strong discrimination for in-hospital mortality between postoperative days 1 and 7 with area under the curve ranging 0.82-0.85. Calibration of the SCAI SHOCK classification improved daily. Serial SCAI SHOCK classification demonstrated consistent good accuracy and enhanced discrimination over time to predict in-hospital mortality in PCS. In-hospital mortality increased progressively with both higher shock stages and prolonged shock duration. Serial SCAI SHOCK assessment provides additional prognostic value over only initial postoperative staging.

Verified
Journal Article
Open access
PDF file
BBB. Ufuk Baldan
B. Ufuk Baldan
PKPatrick Klein
Patrick Klein
Lauran StögerLauran Stöger
Lauran Stöger
RKRobert J.M. Klautz
Robert J.M. Klautz
Meindert PalmenMeindert Palmen
Meindert Palmen
Background/Objectives: Left ventricular (LV) pseudoaneurysm is a rare but life-threatening complication after acute myocardial infarction, often resulting from inadequate excision of damaged myocardium and use of only a xenopericardial patch during primary LV free wall rupture repair. Methods: A 62-year-old female developed a giant LV pseudoaneurysm one year after initial surgical repair of a free wall rupture with a xenopericardial patch. Imaging confirmed a large pseudoaneurysm with a broad neck and mural thrombus. She underwent pseudoaneurysmectomy, LV reconstruction with a Dacron patch overlaid by a xenopericardial patch, and concomitant mitral and tricuspid valve repair. Results: Surgical exploration revealed a broad-necked pseudoaneurysm and dehisced patch material. The aneurysm was resected, and the LV was reconstructed, resulting in the exclusion of the pseudoaneurysm and improvement of the shape and function. The patient recovered uneventfully and was discharged in good clinical condition with restored LV function. Conclusions: Pseudoaneurysm formation after LV free wall rupture repair is often due to insufficient resection and the use of only a xenopericardial patch. Surgical management with complete excision, Dacron patch reconstruction, and xenopericardial reinforcement facilitates the favorable remodeling of LV geometry and function, and reduces the risk of recurrence.

18 August 2026 in JACC: Advances
Verified
Journal Article
Open access
BBB. Ufuk Baldan
B. Ufuk Baldan
MVMariëlle C. Van de Veerdonk
Mariëlle C. Van de Veerdonk
PTPieter-Roel Tuinman
Pieter-Roel Tuinman
SESusanne Eberl
Susanne Eberl
JHJosé P.S. Henriques
José P.S. Henriques
PKPatrick Klein
Patrick Klein
Although plasma lactate levels have established prognostic value in cardiac critical care, current shock thresholds are largely derived from nonsurgical cardiogenic shock populations and may not apply to postcardiotomy patients. The objectives of the study were to examine the association between plasma lactate levels during the first 5 postoperative days (PODs) and in-hospital mortality in postcardiotomy patients, and to compare the discriminative performance with the SCAI (Society of Cardiovascular Angiography and Interventions) SHOCK classification. This retrospective, multicenter study included consecutive adult postcardiotomy patients from 2 academic centers between 2015 and 2024. Plasma lactate levels were measured every 6 hours, with levels of >2.0 mmol/L considered elevated. The primary endpoint was in-hospital mortality. Among the 8,519 patients, the median age was 68 years (Q1-Q3: 59-74 years) and 72% were males. Overall in-hospital mortality was 2%. The highest levels of plasma lactate were observed on POD 2, with 46% of patients having elevated plasma lactate, declining thereafter. In-hospital mortality increased significantly at plasma lactate levels ≥5.0 mmol/L. Every 1 mmol/L increase in plasma lactate was independently associated with higher in-hospital mortality risk after multivariable adjustment. The SCAI SHOCK classification demonstrated higher discriminative performance to predict in-hospital mortality compared to plasma lactate on POD 1 (area under the curve: 0.81 vs 0.75; P = 0.050), whereas values were comparable on the following PODs. Elevated plasma lactate levels were common after cardiac surgery and independently associated with in-hospital mortality, with risk rising exponentially from ≥5.0 mmol/L. No statistically significant differences in discriminative performance between plasma lactate, SCAI SHOCK classification, and EuroSCORE (European System for Cardiac Operative Risk Evaluation) II were observed.